Aerium Therapeutics Advances Next Generation Antibodies to Protect Immunocompromised Persons Against COVID-19 October 4, 2023
Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update September 29, 2023
Doceree raises $35 million in Series B funding, led by Creaegis with participation from Eight Roads Ventures and F-Prime Capital September 27, 2023
Avalyn Raises $175 Million in Oversubscribed Series C Financing to Advance Inhaled Pulmonary Fibrosis Programs into Later Stage Clinical Studies September 27, 2023
All Pregnant Women Should Be Screened for Blood-Pressure Disorders, U.S. Advisers Say September 19, 2023
Equip nabs additional investment to expand virtual eating disorder treatment services to adult patients September 19, 2023